M. Steiner

Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study.

G. Criner, H. Farber, N. Hill, 2006, Chest.

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension

I. Preston, M. Steiner, M. K. Steiner, 2008, Vascular health and risk management.

World Health Organization Class III COPD-associated pulmonary hypertension: are we there yet in understanding the pathobiology of the disease?

M. Steiner, 2009, Chest.

Transitions and Combination Therapy for Pulmonary Arterial Hypertension

N. Hill, M. Steiner, T. Hirschtritt, 2008 .

Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.

N. Hill, J. Klinger, I. Preston, 2005, Current opinion in pharmacology.

Effects of a multiple mild infra-red-A induced hyperthermia on central and peripheral pulse waves in hypertensive patients

B. Meffert, H. Meffert, M. Steiner, 1991, Medical and Biological Engineering and Computing.

Interleukin-6 Overexpression Induces Pulmonary Hypertension

E. Mark, E. Mark, A. Waxman, 2009, Circulation research.

Systolic right ventricular function assessment by pulsed wave tissue Doppler imaging of the tricuspid annulus.

C. Seiler, D. Tüller, A. Wahl, 2005, Swiss medical weekly.